8-KOther EventsExhibits & Filings

Cencora, Inc. 8-K Report, Corporate Update (Jul 31, 2012)

Filed July 31, 2012For Securities:COR

Summary

AmerisourceBergen Corporation (now Cencora, Inc.) filed an 8-K on July 31, 2012, to disclose changes in its reportable business segments, effective for the quarter ended June 30, 2012. The company acquired World Courier Group, Inc. during the quarter and determined that World Courier's operations do not meet the criteria for aggregation with existing segments like AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG). Consequently, ABDC and ABSG will now be reported together under the "Pharmaceutical Distribution" segment. The results of World Courier and AmerisourceBergen Consulting Services (ABCS) are deemed not significant enough for separate disclosure. Therefore, these segments will be included in an "Other" category in future financial reporting. The filing also includes unaudited segment financial information for the first three quarters of fiscal years 2012 and 2011 as an exhibit, providing investors with historical data under the new segment structure.

Key Highlights

  • 1AmerisourceBergen is changing its reportable business segments for financial reporting, effective from the quarter ending June 30, 2012.
  • 2The acquisition of World Courier Group, Inc. triggered this segment realignment.
  • 3AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG) will now be combined and reported as the "Pharmaceutical Distribution" segment.
  • 4World Courier Group, Inc. and AmerisourceBergen Consulting Services (ABCS) will be reported within an "Other" segment due to their relative insignificance for separate disclosure.
  • 5The company will provide unaudited segment financial information for the first three quarters of fiscal years 2012 and 2011 as Exhibit 99.1.
  • 6This change impacts how investors will view the company's performance across different operational areas in future filings.

Frequently Asked Questions

The main reason for this filing is to announce a change in how AmerisourceBergen organizes and reports its business segments for financial reporting purposes, primarily due to the recent acquisition of World Courier Group, Inc. and the determination that World Courier's operations are distinct.

Going forward, the results of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG) will be combined and reported as a single 'Pharmaceutical Distribution' segment. The operations of World Courier Group, Inc. and AmerisourceBergen Consulting Services (ABCS) will be aggregated and reported in an 'Other' segment.

Exhibit 99.1 attached to this filing contains unaudited segment financial information for the first three quarters of fiscal years 2012 and 2011, reflecting the segment structure that will be used in future SEC filings.

Yes, this change will affect your analysis as the reported segments are being redefined. Investors will need to adapt to the new 'Pharmaceutical Distribution' and 'Other' segment reporting structure to accurately compare historical and future performance trends.